Peer-Reviewed Publication
Dermatol Ther (Heidelb)2026August 25, 2026Journal Article
Emerald Touchless Sensor Quantifies Nighttime Scratching and Sleep Quality in Children With Atopic Dermatitis: PEDISTAD EMERALD Study.
Cory J Rubin1, Lara W Lee2, Amal Assa'ad3, Irene Lara-Corrales4, Dina Katabi5,6, Hariharan Rahul5, Siqiao Ruan5, Pranav Krishna5, Rumen Hristov5, Karen J Chandross7, Rajan Gupta8, Marius Ardeleanu9, Annie Zhang10
1Michigan Dermatology Institute, Waterford, MI, USA.
2Medical University of South Carolina, Charleston, SC, USA.
3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
4Division of Dermatology, The Hospital for Sick Children, Toronto, ON, Canada.
5Emerald Innovations, Cambridge, MA, USA.
6Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.
7Sanofi, Morristown, NJ, USA.
8Sanofi, 450 Water St, Cambridge, MA, 02141, USA.
9Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
10Sanofi, 450 Water St, Cambridge, MA, 02141, USA. Annie.Zhang@sanofi.com.
Abstract
INTRODUCTION: In children with atopic dermatitis (AD), itch-related nighttime scratching is associated with significant sleep disturbances. The aim of this study is to report the feasibility of using the Emerald touchless sensor to quantify nighttime scratching and sleep patterns in pediatric patients.
METHODS: PEDISTAD EMERALD (NCT05235724), an open-label, 12-week, exploratory study, included 20…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans